middle.news
How Cleo Diagnostics Is Poised to Transform Ovarian Cancer Detection by 2026
3:01pm on Friday 31st of October, 2025 AEDT
•
Healthcare
Read Story
How Cleo Diagnostics Is Poised to Transform Ovarian Cancer Detection by 2026
3:01pm on Friday 31st of October, 2025 AEDT
Key Points
Constructive second pre-submission meeting with U.S. FDA
Acquisition of ~1,600 biobank samples for test refinement
Health economic study underway to support U.S. reimbursement
U.S. clinical trial recruitment on track for Q1 2026 completion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE